Nuveen’s Lyell Immunopharma LYEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-32,059
Closed -$345K 3345
2025
Q1
$345K Hold
32,059
﹤0.01% 3006
2024
Q4
$410K Sell
32,059
-10,765
-25% -$213K ﹤0.01% 3045
2024
Q3
$1.18M Buy
42,824
+661
+2% +$19.4K ﹤0.01% 2678
2024
Q2
$1.22M Sell
42,163
-440
-1% -$20.9K ﹤0.01% 2630
2024
Q1
$1.9M Buy
42,603
+6,128
+17% +$262K ﹤0.01% 2429
2023
Q4
$1.42M Sell
36,475
-88
-0.2% -$3.17K ﹤0.01% 2574
2023
Q3
$1.07M Buy
36,563
+7,005
+24% +$333K ﹤0.01% 2546
2023
Q2
$1.88M Buy
29,558
+7,178
+32% +$397K ﹤0.01% 2378
2023
Q1
$1.06M Sell
22,380
-2,471
-10% -$132K ﹤0.01% 2587
2022
Q4
$1.73M Sell
24,851
-4,334
-15% -$431K ﹤0.01% 2454
2022
Q3
$4.28M Sell
29,185
-707
-2% -$95.7K ﹤0.01% 1993
2022
Q2
$3.9M Buy
29,892
+2,202
+8% +$225K ﹤0.01% 2111
2022
Q1
$2.83M Buy
27,690
+24,046
+660% +$2.91M ﹤0.01% 2353
2021
Q4
$662K Buy
3,644
+1,354
+59% +$302K ﹤0.01% 2996
2021
Q3
$678K Buy
+2,290
New +$686K ﹤0.01% 3111

Other funds holding LYEL